Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01956669
Title Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors GlaxoSmithKline
Indications
Therapies
Age Groups: child
Covered Countries USA | FRA | ESP | CAN

Facility Status City State Zip Country Details
Novartis Investigative Site Long Beach California 90801 United States Details
Novartis Investigative Site Madera California 93638-8762 United States Details
Novartis Investigative Site Orange California 92868 United States Details
Novartis Investigative Site Palo Alto California 94304 United States Details
Novartis Investigative Site San Francisco California United States Details
Novartis Investigative Site Hartford Connecticut 06106 United States Details
Novartis Investigative Site Orlando Florida 32806 United States Details
Novartis Investigative Site Saint Petersburg Florida 33701 United States Details
Novartis Investigative Site Chicago Illinois 60611 United States Details
Novartis Investigative Site Indianapolis Indiana 46202 United States Details
Novartis Investigative Site Minneapolis Minnesota 55404 United States Details
Novartis Investigative Site Kansas City Missouri 64108 United States Details
Novartis Investigative Site Saint Louis Missouri 63110 United States Details
Novartis Investigative Site Hackensack New Jersey 07601 United States Details
Novartis Investigative Site New York New York 10032 United States Details
Novartis Investigative Site Chapel Hill North Carolina 27599 United States Details
Novartis Investigative Site Charlotte North Carolina 28203 United States Details
Novartis Investigative Site Cincinnati Ohio 45229 United States Details
Novartis Investigative Site Nashville Tennessee 37212 United States Details
Novartis Investigative Site Dallas Texas 75235 United States Details
Novartis Investigative Site Fort Worth Texas 76104 United States Details
Novartis Investigative Site Houston Texas 77030 United States Details
Novartis Investigative Site Norfolk Virginia 23507 United States Details
Novartis Investigative Site Seattle Washington 98105 United States Details
Novartis Investigative Site Toronto Ontario M5G 1X8 Canada Details
Novartis Investigative Site Montreal Quebec H3T 1C5 Canada Details
Novartis Investigative Site Praha 5 150 05 Czechia Details
Novartis Investigative Site Paris Cedex 05 75248 France Details
Novartis Investigative Site Budapest 1094 Hungary Details
Novartis Investigative Site Kosice 041 66 Slovakia Details
Novartis Investigative Site Madrid 28009 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field